
Toxicity study of separase inhibitor-Sepin-1 in Sprague-Dawley rats.

Sepin-1 is a small compound that inhibits the enzymatic activity of Separase and growth of cancer cells. As part of the IND-enabling studies to develop Sepin-1 as a chemotherapeutic agent, here we have profiled toxicity Sepin-1 in mice Sprague-Dawley in setting good laboratory practice (GLP). The maximum tolerated dose (MTD) of Sepin-1 in mice is 40 mg / kg in a single dose study and 20 mg / kg dose study for 7 days in a row.
Toxicity study consists of two parts-Main Study and Restoration Study. Sepin-1 to 0 (control), 5 (low dose), 10 (median dose), and 20 (high dose) mg / kg given by bolus intravenous injection to mice once a day for 28 consecutive days. The animals were euthanized at the Main Study Day 29, whereas in the study animals were allowed to recover Recovery for 28 days after 28 days Sepin-1 dose before they were euthanized on Day 29 of the off-dose periods.
Although the effects of Sepin-1 in low and median doses were minimal, hematological analysis shows that high doses of Sepin-1 associated with a decrease in red blood cells and hemoglobin, and an increase in the number of reticulocytes and platelets and mean corpuscular volume. Clinical chemistry showed that Sepin-1 causes increases in total bilirubin and a decrease in creatine kinase. histopathological analysis showed Sepin-1 results in minimal bone marrow erythroid hyperplasia, minimal to moderate hematopoiesis extramedullary spleen, minimal depletion of lymphoid spleen, minimal to mild thymic lymphoid depletion, and minimal to rats mild mandibular lymph nodes of lymphoid hyperplasia in men and women on Main Learn.
Those abnormal changes that Sepin-1 depending on the dose and largely reversible after a 28-day recovery period in animals of Recovery Study. Based on our results, we conclude that Sepin-1 at pharmacological dose (5-10 mg / kg) was well-tolerated, with no significant levels of mortality or morbidity, and can be developed as a potential new drug for treating Separase-expressed tumors.

Cohesin cleavage by separase enhanced with different substrate
Chromosome segregation began when a cysteine protease, separase, splitting Scc1 transition subunit of cohesin at the metaphase-to-anaphase. Separase inhibited before metaphase with securin tightly bound protein, which contains motifs separase pseudosubstrate blocking the active site.
To investigate the substrate specificity and regulation separase, here we developed a system to produce recombinant human separase securin free. Using these enzymes, we identified motif Scc1 LPE on a substrate different from the cleavage site and necessary for the rapid and specific cleavage of the substrate. LPE Securin also contain conserved motifs, and we provide evidence that this sequence motif involvement Scc1 separase block LPE. Our results indicate that rapid cohesin cleavage by separase require interaction substrate docking outside the active site. This interaction is blocked by securin, providing a second mechanism which inhibits securin cohesin cleavage.
eat-dose pharmacokinetic study Sepin-1 in mice. Sepin-1 intravenously to mice Sprague-Dawley once a day for 28 days in three different (5, 10 and 20mg / kg) dose. Blood samples were taken after dosing on days 1 and 28. Sepin-1 is not stable in phosphate-buffered saline at the base and stable pH buffer such as citric acid-buffered saline (pH 4.0). UHPLC-MS analysis showed Sepin-1 rapidly metabolized in vivo.
JTC-801 |
|||
A8456-5 | ApexBio | 5 mg | EUR 108 |
Description: JTC 801 is a high affinity, selective KOR-3 (NOP) receptor antagonist (Ki = 8.2 nM). Displays approximately 12.5-, 129- and 1055-fold selectivity over human ?-, ?- and ?-opioid receptors respectively. |
JTC-801 |
|||
A8456-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 119 |
Description: JTC 801 is a high affinity, selective KOR-3 (NOP) receptor antagonist (Ki = 8.2 nM). Displays approximately 12.5-, 129- and 1055-fold selectivity over human ?-, ?- and ?-opioid receptors respectively. |
JTC-801 |
|||
A8456-50 | ApexBio | 50 mg | EUR 328 |
Description: JTC 801 is a high affinity, selective KOR-3 (NOP) receptor antagonist (Ki = 8.2 nM). Displays approximately 12.5-, 129- and 1055-fold selectivity over human ?-, ?- and ?-opioid receptors respectively. |
Goat polyclonal antibody for Cytomegalovirus |
|||
801 | Virostat | 1 ml | EUR 272.94 |
Description: This is goat polyclonal antibody against Cytomegalovirus AD 169 for WB, ELISA. |
(+)-MK 801 Maleate |
|||
A8896-10 | ApexBio | 10 mg | EUR 105 |
Description: (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM [1].MK 801 is a potent anticonvulsant exhibits both anxiolytic and sympathomimetic properties. |
(+)-MK 801 Maleate |
|||
A8896-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113 |
Description: (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM [1].MK 801 is a potent anticonvulsant exhibits both anxiolytic and sympathomimetic properties. |
(+)-MK 801 Maleate |
|||
A8896-50 | ApexBio | 50 mg | EUR 266 |
Description: (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM [1].MK 801 is a potent anticonvulsant exhibits both anxiolytic and sympathomimetic properties. |
(+)-MK 801 Hydrogen Maleate |
|||
B2326-25 | Biovision | EUR 349 |
(+)-MK 801 Hydrogen Maleate |
|||
B2326-5 | Biovision | EUR 131 |
(-)-MK 801 Hydrogen Maleate |
|||
B2327-25 | Biovision | EUR 349 |
(-)-MK 801 Hydrogen Maleate |
|||
B2327-5 | Biovision | EUR 131 |
pSMPUW-GFP-LC3 Lentiviral Expression Vector |
|||
LTV-801 | Cell Biolabs | 10 µg | EUR 1204 |
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included. |
OxiSelect In Vitro Nitric Oxide (Nitrite / Nitrate) Assay Kit (Fluorometric) |
|||
STA-801 | Cell Biolabs | 100 assays | EUR 473 |
Description: Cell Biolabs? OxiSelect Nitric Oxide (Nitrite/Nitrate) Assay Kit is a simple, colorimetric assay that quantitatively measures NO in various samples by NO2-/NO3- determination. First, the nitrate (NO3-) in the sample is converted to nitrite (NO2-) by nitrate reductase enzyme. Next, total nitrite is detected with Griess Reagents as a colored azo dye product (absorbance 540 nm). Each kit provides sufficient reagents to perform up to 100 assays using a 96-well microtiter plate format, including blanks, standards and unknown samples. The kit is suitable for serum, plasma, urine, saliva, lysates, and media (see Preparation of Samples) with detection sensitivity limit of ~ 2 µM (in 50 µL sample volume). |
Tris EDTA Saline, 10mM Tris HCl , 1mM EDTA, 2M Nacl |
|||
T8150-801 | GenDepot | 8L | EUR 120 |
pMXs-GFP-LC3 Retroviral Vector |
|||
RTV-801 | Cell Biolabs | 10 ?g | EUR 1169 |
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included. |
Recombinant (E.Coli) Human Myoglobin |
|||
RP-801 | Alpha Diagnostics | 500 ug | EUR 408 |
SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Spike RBD Recombinant Protein |
|||
21-801 | ProSci | 0.1 mg | EUR 485 |
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biologicalprocesses that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Knownreceptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein ofcoronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Mostnotable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike(S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogenand a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells throughinteraction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits,S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor.S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizingantibodyand T-cell responses, as well as protective immunity. |
Dermatopontin Recombinant Protein |
|||
91-801 | ProSci | 0.05 mg | EUR 490.25 |
Description: Dermatopontin, also known as Tyrosine-rich acidic matrix protein, TRAMP and DPT, is a secreted protein which belongs to the dermatopontin family. DPT is expressed in various tissues, such as fibroblasts, heart, skeletal muscle, brain and pancreas. It seems to mediate adhesion by cell surface integrin binding. DPT may serve as a communication link between the dermal fibroblast cell surface and its extracellular matrix environment. DPT can enhance TGFB1 activity through interaction with decorin. In addition, DPT accelerates collagen fibril formation, stabilizes collagen fibrils against low-temperature dissociation and inhibits cell proliferation. |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCA0801-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), APC conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCAP0801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCAP0801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC810801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC810801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCB0801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Biotin conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCB0801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Biotin conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC550801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF555 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC550801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF555 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC430801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF543 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC430801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF543 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC470801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF647 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC470801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF647 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC880801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF488A conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC880801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF488A conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC940801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF594 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC940801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF594 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCP0801-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), PerCP conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC040801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF405S conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC040801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF405S conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC050801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF405M conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC050801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF405M conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCR0801-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), RPE conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNUB0801-100 | Biotium | 100uL | EUR 209 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Concentration: 0.2mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNUB0801-500 | Biotium | 500uL | EUR 458 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Concentration: 0.2mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC680801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF568 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC680801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF568 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC700801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF770 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC700801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF770 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC400801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF640R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC400801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF640R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC610801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF660R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC610801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF660R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC800801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNC800801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCH0801-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNCH0801-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
|||
BNUM0801-50 | Biotium | 50uL | EUR 395 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), 1mg/mL |
96 WELL WHITE LOW PROFILE PCR MICROPLATE FOR AB |
|||
PCR-96-LP-AB-W | CORNING | 25/pk | EUR 388 |
Description: PCR Plates & Tubes; A354 PCR Plate-Axygen |
Recombinant Neisseria Gonorrhoeae lptD Protein (aa 1-801) |
|||
VAng-Wyb2182-inquire | Creative Biolabs | inquire | Ask for price |
Description: Neisseria Gonorrhoeae (strain ATCC 700825 / FA 1090) LPS-assembly protein lptD, recombinant protein. |
Recombinant Streptococcus Pyogenes ftsK Protein (aa 1-801) |
|||
VAng-Cr8109-inquire | Creative Biolabs | inquire | Ask for price |
Description: Streptococcus Pyogenes serotype M18 DNA translocase FtsK (ftsK), recombinant protein. |
Prostate Specific Antigen (PSA); Clone KLK3/801 (Concentrate) |
|||
RA0009-C.1 | ScyTek Laboratories | 0.1 ml | EUR 125 |
Prostate Specific Antigen (PSA); Clone KLK3/801 (Concentrate) |
|||
RA0009-C.5 | ScyTek Laboratories | 0.5 ml | EUR 300 |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCA1256-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), APC conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC811256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF680R conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC811256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF680R conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCAP1256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCAP1256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCB1256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Biotin conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCB1256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Biotin conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC471256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF647 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC471256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF647 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC551256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF555 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC551256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF555 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC431256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF543 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC431256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF543 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC881256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF488A conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC881256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF488A conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC941256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF594 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC941256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF594 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCH1256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCH1256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCP1256-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), PerCP conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC041256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405S conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC041256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405S conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNCR1256-250 | Biotium | 250uL | EUR 383 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), RPE conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNUB1256-100 | Biotium | 100uL | EUR 209 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Concentration: 0.2mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNUB1256-500 | Biotium | 500uL | EUR 458 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Concentration: 0.2mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC681256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF568 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC681256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF568 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC701256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF770 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC701256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF770 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC051256-100 | Biotium | 100uL | EUR 199 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405M conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
|||
BNC051256-500 | Biotium | 500uL | EUR 544 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405M conjugate, Concentration: 0.1mg/mL |
One of the major metabolite is stirring the amine of 2,2-dimethyl-5-nitro-2H-benzimidazole (named Sepin-1.55). Sepin-concentration in the blood samples was 1.55 Sepin-1 depending on the dose and used for pharmacokinetic analysis Sepin-1. Tmax was about 5-15 minutes.
No Comment